Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma.
Marks JL, Broderick S, Zhou Q, Chitale D, Li AR, Zakowski MF, Kris MG, Rusch VW, Azzoli CG, Seshan VE, Ladanyi M, Pao W.
Marks JL, et al. Among authors: li ar.
J Thorac Oncol. 2008 Feb;3(2):111-6. doi: 10.1097/JTO.0b013e318160c607.
J Thorac Oncol. 2008.
PMID: 18303429
Free article.